Following the Divestiture of Loss-Making Operations, Token Cat Limited Authorizes Its U.S. Subsidiary to Evaluate a Potential $ 500 Million Fundraising Plan for Nuclear Fission Research and M&A to Address the Growing Clean Energy Demand of AI Computing
BEIJING, Nov. 14, 2025 /PRNewswire/ -- Token Cat Limited (Nasdaq: TC) today announced…
Clover Health Announces Chelsea Clinton to Step Down from Board Following Eight Years of Service
October 31, 2025 16:05 ET | Source: Clover Health Investments, Corp. WILMINGTON,…
DAR GLOBAL PLANS TO LAUNCH TRUMP PLAZA JEDDAH IN SECOND COLLABORATION WITH THE TRUMP ORGANIZATION, FOLLOWING THE SUCCESS OF TRUMP TOWER JEDDAH
JEDDAH, Saudi Arabia, Sept. 29, 2025 /PRNewswire/ -- Dar Global (LSE: DAR),…
Following the Appointment of Dr. Doug Buerger as COO, Jiuzi Holdings, Inc.’s Board Endorses Crypto Asset Investment Policy Allowing Up to $1 Billion Deployment
HANGZHOU, China, Sept. 24, 2025 /PRNewswire/ -- Jiuzi Holdings, Inc. (NASDAQ: JZXN;…
Italgas Expands Use of Picarro Network Intelligence Solutions Following Acquisition of 2i Rete Gas
SANTA CLARA, Calif. and MILAN, Sept. 10, 2025 /PRNewswire/ -- Picarro Inc., a…
Wi-Charge Adds CMO and VP of People to Executive Team Following Series C Funding
Strategic Hires Underscore Momentum as Company Expands Global Commercialization of Long-Range Wireless…
NordValor Launches Advanced AI Trading Engine Following Global Recognition as the Platform of Choice for Professional Traders
London UK, July 31, 2025 (GLOBE NEWSWIRE) -- NordValor reviews are in…
Treehouse Launches TREE Token Across Binance, OKX, Coinbase, and Top Exchanges Following Token Generation Event
With listings on prominent CEXs and DEXs, Treehouse, the Decentralized Fixed Income…
Egg Medical Announces U.S. Patent and Trademark Office Issues Final Rejection of All Claims in Rampart IC’s Radiation Shield Patent Following a Reexamination Challenge
ST. PAUL, Minn., July 30, 2025 /PRNewswire/ -- In a significant development in…
Nxera Pharma to Receive US$4.8 Million in Milestone Payments Following Centessas Initiation of Clinical Development of ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist
July 04, 2025 03:00 ET | Source: Nxera Pharma Tokyo, Japan and…
